Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Arduan
2. Bromide, Pipecurium
3. Bromide, Pipecuronium
4. Dibromide Pipecuronium
5. Dibromide, Dihydrate Pipecuronium
6. Dihydrate Pipecuronium Dibromide
7. Pipecurium
8. Pipecurium Bromide
9. Pipecuronium
10. Pipecuronium Dibromide, (16 Alpha)-isomer
11. Pipecuronium Dibromide, (17 Alpha)-isomer
12. Pipecuronium Dibromide, (3 Beta)-isomer
13. Pipecuronium Dibromide, Dihydrate
14. Pipecuronium, Dibromide
15. Rgh 1106
16. Rgh-1106
17. Rgh1106
1. 52212-02-9
2. Pipecurium Bromide
3. Arduan
4. Rgh-1106
5. Rgh 1106
6. R6zty81re1
7. Pipecuronium Bromide Anhydrous
8. Pipecuronium (bromide)
9. [(2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-17-acetyloxy-2,16-bis(4,4-dimethylpiperazin-4-ium-1-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl] Acetate;dibromide
10. Pipecuronium Bromide Hydrate
11. Pipecuronio Bromuro [spanish]
12. Einecs 257-740-4
13. Unii-r6zty81re1
14. Pipecuronium Bromide [usan:inn:ban]
15. Ncgc00182708-01
16. Dsstox_cid_3478
17. Dsstox_rid_77044
18. Dsstox_gsid_23478
19. Schembl42154
20. 4,4'-(3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1,1-dimethylpiperazinium)dibromide, Diacetate (ester)
21. Chebi:8231
22. Pipecurium Bromide [mi]
23. Chembl1200722
24. Dtxsid8023478
25. Hy-b0743a
26. Tqp0582
27. Pipecuronium Bromide [inn]
28. Pipecuronium Bromide [jan]
29. Pipecuronium Bromide [usan]
30. Pipecuronium Bromide [vandf]
31. Tox21_113014
32. Pipecuronium Bromide [mart.]
33. Akos037653998
34. Pipecuronium Bromide (jan/usan/inn)
35. Ks-1465
36. 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetoxy)androstane-2,16-diyl)bis(1,1-dimethylpiperazinium) Dibromide
37. Pipecuronium Bromide [orange Book]
38. Piperazinium, 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-, Dibromide
39. Piperazinium, 4,4'-(3,17-dihydroxyandrostan-2,16-diyl)bis(1,1-dimethyl-, Dibromide, Diacetate
40. Cas-52212-02-9
41. Cs-0009634
42. D00764
43. A828983
44. Q-101016
45. Q4363210
46. (2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2,16-bis(4,4-dimethylpiperazin-4-ium-1-yl)androstane Dibromide
47. 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-piperazinium) Dibromide
48. 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-piperazinium)dibromide
49. 4,4'-(3.alpha.,17.beta.-dihydroxy-5.alpha.-androstan-2.beta.,16.beta.-ylene)bis(1,1-dimethylpiperazinium)dibromide, Diacetate (ester)
50. 4,4\'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-piperazinium) Dibromide
51. Piperazinium, 4,4'-((2.beta.,3.alpha.,5.alpha.,16.beta.,17.beta.)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-, Dibromide
52. Piperazinium, 4,4'-[(2
53. A,3
54. A,5
55. A,16
56. A,17
57. A)-3,17-bis(acetyloxy)androstane-2,16-diyl]bis[1,1-dimethyl-, Dibromide (9ci)
Molecular Weight | 762.7 g/mol |
---|---|
Molecular Formula | C35H62Br2N4O4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 6 |
Exact Mass | 762.31173 g/mol |
Monoisotopic Mass | 760.31378 g/mol |
Topological Polar Surface Area | 59.1 Ų |
Heavy Atom Count | 45 |
Formal Charge | 0 |
Complexity | 1060 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Neuromuscular Nondepolarizing Agents
Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. (See all compounds classified as Neuromuscular Nondepolarizing Agents.)
Nicotinic Antagonists
Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)
M - Musculo-skeletal system
M03 - Muscle relaxants
M03A - Muscle relaxants, peripherally acting agents
M03AC - Other quaternary ammonium compounds
M03AC06 - Pipecuronium bromide
Market Place
ABOUT THIS PAGE
37
PharmaCompass offers a list of Pipecuronium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pipecuronium manufacturer or Pipecuronium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pipecuronium manufacturer or Pipecuronium supplier.
PharmaCompass also assists you with knowing the Pipecuronium API Price utilized in the formulation of products. Pipecuronium API Price is not always fixed or binding as the Pipecuronium Price is obtained through a variety of data sources. The Pipecuronium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_3478 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_3478, including repackagers and relabelers. The FDA regulates DSSTox_CID_3478 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_3478 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DSSTox_CID_3478 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DSSTox_CID_3478 supplier is an individual or a company that provides DSSTox_CID_3478 active pharmaceutical ingredient (API) or DSSTox_CID_3478 finished formulations upon request. The DSSTox_CID_3478 suppliers may include DSSTox_CID_3478 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_CID_3478 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DSSTox_CID_3478 DMF (Drug Master File) is a document detailing the whole manufacturing process of DSSTox_CID_3478 active pharmaceutical ingredient (API) in detail. Different forms of DSSTox_CID_3478 DMFs exist exist since differing nations have different regulations, such as DSSTox_CID_3478 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DSSTox_CID_3478 DMF submitted to regulatory agencies in the US is known as a USDMF. DSSTox_CID_3478 USDMF includes data on DSSTox_CID_3478's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DSSTox_CID_3478 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DSSTox_CID_3478 suppliers with USDMF on PharmaCompass.
DSSTox_CID_3478 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_CID_3478 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_3478 GMP manufacturer or DSSTox_CID_3478 GMP API supplier for your needs.
A DSSTox_CID_3478 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_3478's compliance with DSSTox_CID_3478 specifications and serves as a tool for batch-level quality control.
DSSTox_CID_3478 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_3478 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_CID_3478 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_3478 EP), DSSTox_CID_3478 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_3478 USP).